Profile
Margaret Marshall worked as a Director of Clinical Research & Oncology at Pfizer Inc. from 2004 to 2012.
She then worked as a Senior Director of Clinical Development at Kite Pharma, Inc. from 2012 to 2014.
From 2014 to 2018, she worked as a Senior Director of Clinical Research at Kyowa Kirin Pharmaceutical Development Ltd.
Currently, she is working as the Chief Medical Officer at Barinthus Biotherapeutics Plc, a position she started in 2020.
Dr. Marshall received her undergraduate degree from the California Institute of Technology and her doctorate degree from the University of California San Diego.
Former positions of Margaret Marshall
| Companies | Position | End |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2023-07-19 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2018-01-31 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 2014-08-31 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2012-09-30 |
Training of Margaret Marshall
| University of California San Diego | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Margaret Marshall
